Prescott Group Capital Management’s Charles River Laboratories CRL Stock Holding History

Prescott Group Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,500	Closed	-$1.2M	–	257
2024 Q4	$1.2M	Hold	6,500	–	–	0.16%	161
2024 Q3	$1.28M	Hold	6,500	–	–	0.19%	143
2024 Q2	$1.34M	Hold	6,500	–	–	0.21%	132
2024 Q1	$1.76M	Hold	6,500	–	–	0.28%	107
2023 Q4	$1.54M	Hold	6,500	–	–	0.27%	107
2023 Q3	$1.27M	Hold	6,500	–	–	0.28%	101
2023 Q2	$1.37M	Buy	6,500 +2,000	+44%	+$398K	0.3%	102
2023 Q1	$908K	Hold	4,500	–	–	0.21%	118
2022 Q4	$981K	Buy	+4,500	New	+$983K	0.21%	113
2022 Q1	–	Sell	-2,500	Closed	-$942K	–	151
2021 Q4	$942K	Sell	2,500 -118	-5%	-$45.8K	0.21%	121
2021 Q3	$1.08M	Buy	2,618 +50	+2%	+$20.8K	0.3%	103
2021 Q2	$950K	Buy	2,568 +68	+3%	+$22.7K	0.27%	89
2021 Q1	$725K	Buy	+2,500	New	+$695K	0.21%	98
2020 Q2	–	Sell	-3,029	Closed	-$382K	–	97
2020 Q1	$382K	Buy	+3,029	New	+$454K	0.19%	90
2015 Q3	–	Sell	-16,884	Closed	-$1.19M	–	169
2015 Q2	$1.19M	Hold	16,884	–	–	0.24%	114
2015 Q1	$1.34M	Buy	16,884 +6,083	+56%	+$449K	0.27%	105
2014 Q4	$687K	Buy	+10,801	New	+$677K	0.11%	157

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Prescott Group Capital Management's CRL Position: Q1 2025 in Review

Prescott Group Capital Management sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 6,500 shares — an estimated $1.2M sold.

Prescott Group Capital Management first reported a position in CRL in Q4 2014 and held it in 17 quarters. The position peaked at $1.76M in Q1 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

Prescott Group Capital Management reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
Prescott Group Capital Management sold 6,500 Charles River Laboratories shares in Q1 2025, an estimated $1.2M.
Prescott Group Capital Management first reported a position in Charles River Laboratories in Q4 2014 and held it in 17 quarters.
Prescott Group Capital Management's Charles River Laboratories position peaked at $1.76M in Q1 2024.
561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Prescott Group Capital Management's 13F filing for Q1 2025, filed 7 May 2025.